SYMBIO VACCIN
SymbioVaccin expertise in the manufacture and production of medicines for immune stimulation and autovaccine treatment.
SYMBIO VACCIN
Industry:
Alternative Medicine Biotechnology Manufacturing Pharmaceutical
Founded:
1922-01-01
Address:
Herborn, Hessen, Germany
Country:
Germany
Website Url:
http://www.symbiovaccin.de
Total Employee:
11+
Status:
Active
Contact:
49-2772-981 191
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Google Analytics LetsEncrypt SSL By Default Google Universal Analytics Apache Apple Mobile Web App Status Bar Style Google Analytics IP Anonymization TYPO3
Similar Organizations
Atlean
Atlean comprises manufacturing of a dermal filler Atlean which combines a collagen stimulator and hyaluronic acid filler.
Aventis SA
ventis S.A. is engaged in the discovery, development, manufacture, and marketing of branded prescription drugs and human vaccines.
ESSETI Farmaceutici
ESSETI Farmaceutici specializes in the development and production of pharmaceutical drugs like anti-infectives and anti-parasitic drugs.
Porvair Sciences
Porvair Sciences expertise and understanding of life science applications can be applied to special custom manufacture.
Synvolux
Synvolux manufactures and provides products for macromolecules such as DNA, RNA, and protein/peptides.
Official Site Inspections
http://www.symbiovaccin.de
- Host name: 193.53.246.64
- IP address: 193.53.246.64
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Symbio Vaccin"
Symbio Vaccin - Crunchbase Company Profile & Funding
Organization. Symbio Vaccin . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number 49-2772 …See details»
SymbioVaccin GmbH Gesellschaft für Diagnostik und …
SymbioVaccin GmbH Gesellschaft für Diagnostik und Vaccineherstellung mit Sitz in Herborn ist im Handelsregister mit der Rechtsform Gesellschaft mit beschränkter Haftung eingetragen. …See details»
SymbioVaccin GmbH Gesellschaft für Diagnostik und …
Finden Sie Unternehmensinformationen, Mitbewerber, Ansprechpersonen und Finanzdaten für SymbioVaccin GmbH Gesellschaft für Diagnostik und Vaccineherstellung in Herborn, Hessen. …See details»
Pressemappe: SymbioVaccin GmbH - GESUNDHEIT ADHOC
Jan 29, 2013 SymbioVaccin GmbHAuf den Lüppen 835745 HerbornMelanie Meckel und Dr. Lilian SchoeferTel.: 02772/981-128Fax: 02772/981-151eMail: …See details»
EMEA-002442-PIP01-18 - paediatric investigation plan
SymbioVaccin GmbH. Tel. +49 2772981354 E-mail: [email protected]. Decision type W: decision granting a waiver in all age groups for all conditions or indications Decision date …See details»
Symbiovaccin Gesellschaft Fuer Diagnostik Und Vaccineherstellung ...
In 2022, Symbiovaccin Gesellschaft Fuer Diagnostik Und Vaccineherstellung, a Germany based Healthcare organization with 6 employees and revenues of $2M selected Google Tag …See details»
Sinovac and Sinopharm - what do we know about the Chinese …
The parents of a toddler waiting for a liver and bowel transplant are pleading with parents to have the conversation about what they would do in the same situation.See details»
Individuelle Mischungen ätherischer Öle bei Parodontitis
Jan 29, 2013 Auf der Basis des Aromatogramms hat die SymbioVaccin GmbH die verschiedenen Parodolium-Mundwasser entwickelt. Betroffene können das Mundwasser direkt …See details»
Facilitating the development of urgently required combination …
Apr 15, 2024 The range and breadth of human diseases that vaccines routinely protect against are not widely recognised. Vaccines can prevent more than 27 life-threatening conditions and …See details»
Emerging vaccine manufacturers are innovating for the next decade
Apr 29, 2020 1 DCVMN International, Route de Crassier 7, 1262 Nyon, Switzerland. PMID: 32462140 PMCID: PMC7242873 DOI: 10.1016/j.jvacx.2020.100066 Abstract The Developing …See details»
Mehr Sicherheit beim Impfen - Deutsche Gesellschaft für …
Mehr Sicherheit beim Impfen. Trainings für Gesundheitspersonal befördern das Vertrauen in Impfungen gegen Covid-19 und tragen zur Pandemiebekämpfung bei.See details»
First step results from a phase II study of a dendritic cell vaccine in ...
Aug 13, 2024 Laura Ridolfi 1 , Lorena Gurrieri 1 , Nada Riva 1 , Jenny Bulgarelli 1 , Francesco De Rosa 1 , Massimo Guidoboni 1 , Valentina Fausti 1 , Nicoletta Ranallo 1 , Sebastiano …See details»
SymbioVaccin Parodolium Mundwasserkonzentrat (50ml) - idealo
Bereits ab 13,87 € Große Shopvielfalt Testberichte & Meinungen | Jetzt SymbioVaccin Parodolium Mundwasserkonzentrat (50ml) günstig kaufen bei idealo.deSee details»
For vaccine equity: producers work together to advance mRNA
Two years into the pandemic, vaccine inequity continues to be a challenge for the COVID-19 response in the Americas. In lower-middle income countries, only 46.1% of the general …See details»
WHO statement on Solidarity Trial Vaccines - World Health …
Oct 26, 2021 World Health Organization WHO Regional websites When autocomplete results are available use up and down arrows to review and enter to select. Select language Select …See details»
A Systems Biology Workflow for Drug and Vaccine Repurposing ...
Oct 6, 2020 Purpose Coronavirus disease 2019 (COVID-19) is expected to continue to cause worldwide fatalities until the World population develops ‘herd immunity’, or until a vaccine is …See details»
German Federal Government invests 300 Million Euros in CureVac
Jun 15, 2020 The German Federal Minister for Economic Affairs and Energy, Peter Altmaier, and Dietmar Hopp, SAP co-founder and co-founder of the investment company dievini Hopp …See details»
Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent …
Aug 31, 2023 An Omicron BA.4/BA.5 mRNA booster vaccine elicits high neutralizing responses to the BA.4/BA.5 variant and to ancestral SARS-CoV-2, supporting tailoring booster vaccines …See details»
New Vaccine Platform: 'Two-one replicon-and- - pei.de
To stop the current SARS-CoV-2 pandemic, vaccines of high quality, safety, and efficacy are required. Scientists of the Paul-Ehrlich-Institut and the Ludwig Maximilian University at Munich …See details»
Making vaccines accessible to everyone • Biopôle • Switzerland
After having worked in the biotech industry and at the National Institutes of Health in Washington DC, Nicolas joined the World Health Organization in Geneva as a Technical Officer in …See details»